Moderna Withdraws Additional COVID-19 Shots In Japan: What You Need To Know

  • After receiving reports on more contaminated vials and two deaths, Japan has suspended another million doses of Moderna Inc's MRNA COVID-19 vaccine.
  • Black substances were spotted in syringes and a vial, while pink substances were found in a different syringe filled with vaccines at the Okinawa center, Reuters reported citing NHK.
  • Laboratorios Farmacéuticos ROVI, S.A. said it is investigating what happened in the drug product fill/finish manufacturing process. Takeda Pharmaceutical Co Ltd TAK is in charge of distributing the vaccine in Japan.
  • Related Content: Suspected Metallic Particles Behind Moderna's Japan COVID-19 Jab Contamination
  • The suspension of Moderna supplies, more than 2.6 million does in total, comes as Japan battles its worst wave of COVID-19 yet, driven by the contagious Delta variant.
  • Two Japanese regions suspended some Moderna shots after more contamination cases were spotted, the local governments said.
  • Okinawa prefecture, in southern Japan, said it had suspended the use of Moderna shots at a large-scale vaccination center.
  • The Okinawa vaccines are from different Moderna lots already suspended by the Japanese government due to contamination reports. 
  • While Gunma prefecture also said it had paused the use of contaminated lots. In Gunma, an official told AFP: "We continue the use of Moderna lots that are not affected by the incident."
  • The move came a day after the Japanese health ministry said it was investigating the death of two men who received doses from tainted Moderna batches, though the cause of death is unknown.
  • Price Action: MRNA shares are down 1.69% at $375.77 in the premarket on the last check Monday.
  • Photo by Spencer Davis from Pixabay
Market News and Data brought to you by Benzinga APIs
Posted In: BiotechGovernmentNewsHealth CareMoversTrading IdeasGeneralBriefsCOVID-19 CoronavirusCOVID-19 Vaccine
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!